Cargando…

Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy

SARS-CoV-2 infection leads to a heterogenous spectrum of clinical conditions ranging from self-limiting upper airway infection to severe respiratory failure. Carbocysteine is a thioether mucolytic with antioxidant and anti-inflammatory activities. Carbocysteine has been shown to have anti-viral effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bianco, Andrea, Conte, Stefano, Mariniello, Domenica Francesca, Allocca, Valentino, Matera, Maria Gabriella, D’Agnano, Vito, Lanata, Luigi, Cazzola, Mario, Perrotta, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692377/ https://www.ncbi.nlm.nih.gov/pubmed/36362979 http://dx.doi.org/10.3390/life12111824

Ejemplares similares

Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action
por: Pace, Elisabetta, et al.
Publicado: (2022)

Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt?
por: Mariniello, Domenica Francesca, et al.
Publicado: (2022)

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
por: Rogliani, Paola, et al.
Publicado: (2019)

Effects of Different Corticosteroid Doses in Elderly Unvaccinated Patients with Severe to Critical COVID-19
por: Scialò, Filippo, et al.
Publicado: (2022)

Exploring the Network between Adipocytokines and Inflammatory Response in SARS-CoV-2 Infection: A Scoping Review
por: Nigro, Ersilia, et al.
Publicado: (2023)

Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent
por: Cazzola, Mario, et al.
Publicado: (2020)

Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
por: D’Agnano, Vito, et al.
Publicado: (2022)

Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?
por: Perrotta, Fabio, et al.
Publicado: (2020)

Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways
por: Nigro, Ersilia, et al.
Publicado: (2020)

Food, Nutrition, Physical Activity and Microbiota: Which Impact on Lung Cancer?
por: Nigro, Ersilia, et al.
Publicado: (2021)

Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial
por: Wu, Kang, et al.
Publicado: (2016)

Palatability Assessment of Carbocysteine Oral Solution Strawberry Taste Versus Carbocysteine Oral Solution Mint Taste: A Blinded Randomized Study
por: Peng, Yaguang, et al.
Publicado: (2022)

Pulmonary Hypertension and Obesity: Focus on Adiponectin
por: Perrotta, Fabio, et al.
Publicado: (2019)

Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2
por: Perrotta, Fabio, et al.
Publicado: (2023)

Corticosteroids and Delayed Conversion of SARS-CoV-2 RNA Nasopharyngeal Swabs in Hospitalized Patients With COVID 19 Pneumonia
por: Parrella, Roberto, et al.
Publicado: (2022)

COVID-19 and the elderly: insights into pathogenesis and clinical decision-making
por: Perrotta, Fabio, et al.
Publicado: (2020)

Correction to: COVID-19 and the elderly patients: insights into pathogenesis and clinical decision-making
por: Perrotta, Fabio, et al.
Publicado: (2020)

Role of mucolytics in the management of COPD
por: Poole, Phillippa J
Publicado: (2006)

Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study
por: Ferraro, Maria, et al.
Publicado: (2022)

Clinical Characteristics, Exercise Capacity and Pulmonary Function in Post-COVID-19 Competitive Athletes
por: Komici, Klara, et al.
Publicado: (2021)

Possible Role of Carbocysteine Syrup in the Deflation of Percutaneous Endoscopic Gastrostomy Balloons
por: Bassotti, Gabrio, et al.
Publicado: (2023)

Disputes over the production and dissemination of misinformation in the time of COVID-19
por: Cazzola, Mario, et al.
Publicado: (2021)

Aerosol delivery through high-flow nasal therapy: Technical issues and clinical benefits
por: Calabrese, Cecilia, et al.
Publicado: (2023)

Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

Effects of a Long-Term Use of Carbocysteine on Frequency and Duration of Exacerbations in Patients with Bronchiectasis
por: Minov, Jordan, et al.
Publicado: (2019)

The State of Art of Regenerative Therapy in Cardiovascular Ischemic Disease: Biology, Signaling Pathways, and Epigenetics of Endothelial Progenitor Cells
por: Perrotta, Fabio, et al.
Publicado: (2020)

Efficacy of mucolytics and steam therapy in the management of sinusitis among Indians
por: S Balakrishnan, Rajalakshmi, et al.
Publicado: (2023)

Guidance on nebulization during the current COVID-19 pandemic
por: Cazzola, Mario, et al.
Publicado: (2021)

Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma—An Overview
por: D’Agnano, Igea, et al.
Publicado: (2020)

Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism
por: Calabrese, Cecilia, et al.
Publicado: (2022)

Respiratory Paradoxical Adverse Drug Reactions Associated with Acetylcysteine and Carbocysteine Systemic Use in Paediatric Patients: A National Survey
por: Mallet, Pauline, et al.
Publicado: (2011)

A Quality Improvement Approach to Influence Value-based Mucolytic Use in the PICU
por: Gillis, Holly Catherine, et al.
Publicado: (2021)

A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]
por: Kurukulaaratchy, Ramesh J, et al.
Publicado: (2021)

Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis
por: Papadopoulou, Efthymia, et al.
Publicado: (2023)

Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke
por: Patzwaldt, Kristin, et al.
Publicado: (2023)

A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases
por: Addante, Annalisa, et al.
Publicado: (2023)

Mucolytic treatment of chronic rhinosinusitis in a murine model of primary ciliary dyskinesia
por: Yin, Weining, et al.
Publicado: (2023)

New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol
por: Cazzola, Mario, et al.
Publicado: (2013)

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
por: Matera, Maria Gabriella, et al.
Publicado: (2016)

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
por: Matera, Maria Gabriella, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gu3704t2j9l9sikrsm64vt9i6i